These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14760341)

  • 1. Comparison between a sustained administration of carvedilol versus atenolol to reduce restenosis after coronary stenting.
    Cha KS; Kim MH; Kim JW; Kim DI; Kim HJ; Kim DS; Kim JS
    Am Heart J; 2004 Feb; 147(2):E7. PubMed ID: 14760341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
    Chen WH; Kaul U; Leung SK; Lau YK; Tan HC; Leung AW; Lee MK; Li SK; Ng W; Lee PY; Lam KF; Tse HF; Lau CP
    J Invasive Cardiol; 2005 Oct; 17(10):534-8. PubMed ID: 16204748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.
    Jonsson G; Abdelnoor M; Müller C; Kjeldsen SE; Os I; Westheim A
    Cardiology; 2005; 103(3):148-55. PubMed ID: 15785019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
    Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
    N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].
    Kastrati A; Mehilli J; Dirschinger J; Dotzer F; Schuhlen H; Neumann FJ; Fleckenstein M; Pfafferott C; Seyfarth M; Schomig A
    Vestn Rentgenol Radiol; 2012; (2):52-60. PubMed ID: 22730760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty.
    Miketic S; Carlsson J; Tebbe U
    Am Heart J; 2001 Nov; 142(5):E8. PubMed ID: 11685183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model.
    Kim W; Jeong MH; Cha KS; Hyun DW; Hur SH; Kim KB; Hong YJ; Park HW; Kim JH; Ahn YK; Kim MH; Cho JG; Park JT; Park JC; Kang JC
    Circ J; 2005 Jan; 69(1):101-6. PubMed ID: 15635212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
    Martsevich SIu; Koniakhina IP; Alimova EV; Kutishenko NP; Lerman OV
    Ter Arkh; 2001; 73(1):38-41. PubMed ID: 11234138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.
    Tan HC; Lim YT; Rosli TL; Sim KH; Tan KH; Lee CH; Ismail O; Azman W
    Am Heart J; 2004 Dec; 148(6):1007-11. PubMed ID: 15632886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
    N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
    Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
    J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
    Serruys PW; de Jaegere P; Kiemeneij F; Macaya C; Rutsch W; Heyndrickx G; Emanuelsson H; Marco J; Legrand V; Materne P
    N Engl J Med; 1994 Aug; 331(8):489-95. PubMed ID: 8041413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
    Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P;
    Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol for prevention of restenosis after directional coronary atherectomy : final results of the European carvedilol atherectomy restenosis (EUROCARE) trial.
    Serruys PW; Foley DP; Höfling B; Puel J; Glogar HD; Seabra-Gomes R; Goicolea J; Coste P; Rutsch W; Katus H; Bonnier H; Wijns W; Betriu A; Hauf-Zachariou U; van Swijndregt EM; Melkert R; Simon R
    Circulation; 2000 Apr; 101(13):1512-8. PubMed ID: 10747343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents?
    Jung JH; Min PK; Kim JY; Park S; Choi EY; Ko YG; Choi D; Jang Y; Shim WH; Cho SY
    Cardiology; 2005; 104(2):72-5. PubMed ID: 16020923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study.
    Dudek D; Legutko J; Heba G; Bartus S; Partyka L; Huk I; Dembinska-Kiec A; Kaluza GL; Dubiel JS
    Am Heart J; 2004 Apr; 147(4):E12. PubMed ID: 15077095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
    Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate therapy and in-stent restenosis after coronary stenting.
    Lange H; Suryapranata H; De Luca G; Börner C; Dille J; Kallmayer K; Pasalary MN; Scherer E; Dambrink JH
    N Engl J Med; 2004 Jun; 350(26):2673-81. PubMed ID: 15215483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.